Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of FokI (rs10735810) and BsmI (rs1544410) on Treatment of Chronic HCV Patients With Genotype 4.

Journal of clinical laboratory analysis - 1 Nov 2016

Shaker Olfat, Nassar Yasser, Ayoub Shymaa, Elrazki Maissa, Zahra Amr

Abstract excerpt

BACKGROUND AND AIM: Chronic infection with hepatitis C virus (HCV) is a huge problem both globally and at the level of the individual patient. Our aim is to detect the influence of vitamin D receptor gene polymorphisms (BsmI and Fok1) and vitamin D level in HCV patients under treatment with interferon. SUBJECT AND METHODS: Blood samples were taken from 103 HCV patients all of them are genotype 4. They were...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to DNA Mutational Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepacivirus

Share to Hepatitis C, Chronic

Share to Interferons

Share to Pharmacogenomic Testing

Share to Receptors, Calcitriol

Share to Vitamin D

Source

Open in PubMed Open full text

Identifiers

PMID: 27087054
DOI: 10.1002/jcla.21974
PMCID: PMC6807094

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of FokI (rs10735810) and BsmI (rs1544410) on Treatment of Chronic HCV Patients With Genotype 4.PMID 27087054Read ↗

Molecular assessment of vitamin D receptor polymorphism as a valid predictor to the response of interferon/ribavirin-based therapy in Egyptian patients with chronic hepatitis C.Semantic proximity Read ↗

Impact of vitamin D receptor and binding protein gene polymorphisms in clinical and laboratory data of HCV patients: Cross sectional study.Semantic proximity Read ↗

[Association of Vitamin D Receptor Polymorphisms with Response to Antiviral Therapy in Patients with Chronic Hepatitis C].Semantic proximity Read ↗

Association between vitamin D receptor polymorphisms and hepatitis B virus infection susceptibility: A meta-analysis study.Semantic proximity Read ↗

The efficacy of calcitriol treatment in non-alcoholic fatty liver patients with different genotypes of vitamin D receptor FokI polymorphism.Semantic proximity Read ↗

The Influence of Single Nucleotide Polymorphisms on Vitamin D Receptor Protein Levels and Function in Chronic Liver Disease.Semantic proximity Read ↗

Association of Vitamin D Gene Polymorphisms With HCV Infection Outcome.Semantic proximity Read ↗

Vitamin D pathway gene polymorphisms as predictors of hepatitis C virus-related mixed cryoglobulinemia.Semantic proximity Read ↗

Vitamin D pathway gene variants and HCV-2/3 therapy outcomes.Semantic proximity Read ↗

The impact of genetic variations in sofosbuvir metabolizing enzymes and innate immunity mediators on treatment outcome in HCV-infected patients.Semantic proximity Read ↗

Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs.Semantic proximity Read ↗

The vitamin D receptor gene bAt (CCA) haplotype impairs the response to pegylated-interferon/ribavirin-based therapy in chronic hepatitis C patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.